Culp (CULP) EBITDA Margin (2010 - 2026)

Culp (CULP) posted EBITDA Margin of 7.77% for Q1 2026, down 19.59% sequentially from 6.49% in Q4 2025, and down 33.0% YoY from 11.59% in Q1 2025.

Culp (CULP) EBITDA Margin (2010 - 2026) Analysis & Trends

Culp has reported EBITDA Margin for 17 years, with the latest figure at 7.77% in Q1 2026.

Quarterly EBITDA Margin fell 33.0% year-over-year to 7.77% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 2.75% (up 708.0% YoY) and the FY2023 annual result came in at 12.12%, down 1235.0% from the prior year.
EBITDA Margin retreated to 7.77% in Q1 2026 per CULP's latest filing, from 6.49% in the prior quarter.
Over five years, EBITDA Margin peaked at 33.74% in Q4 2022 and troughed at 14.82% in Q1 2023.
A 5-year average of 3.43% and a median of 7.5% in 2022 frame the typical range for EBITDA Margin.
The sharpest annual moves came in 2022 and 2023: EBITDA Margin soared 3154 bps in 2022, then slumped 1619 bps in 2023.
Over 5 years, EBITDA Margin stood at 33.74% in 2022, then plunged by 112 bps to 4.07% in 2023, then sank by 138 bps to 9.7% in 2024, then surged by 33 bps to 6.49% in 2025, then declined by 20 bps to 7.77% in 2026.
According to Business Quant data, EBITDA Margin over the past three periods registered 7.77%, 6.49%, and 3.19% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Albany International	1.67 Bn	1.59 Bn	107.90 Mn	9.75%
2	SMJ International Holdings	291.52 Mn	271.89 Mn	-	-
3	Unifi	140.50 Mn	112.02 Mn	9.12 Mn	-0.09%
4	Culp	41.62 Mn	41.62 Mn	-	-
5	Ping An Biomedical	2.49 Mn	-2.63 Mn	-	-

Download Data